Regulation of Inflammatory Genes in Psoriasis
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 19 Years to 99 Years
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study looks at genes and immune system signals linked to swelling and irritation in psoriasis. Psoriasis is a long-lasting skin condition that can come back. The study is for adults age 19 or older who have psoriasis.
Psoriasis is a chronic and recurrent skin disorder characterized by marked inflammatory changes in the skin. An extensive cytokine network including generated by activated dendritic cells and T cells mediates the formation of psoriatic lesions. These immune-response parameters can be used as markers in the severity and management of the disease after further in-depth studies.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Have a diagnosis of psoriasis.
- Be age 19 or older.
- Have any Fitzpatrick skin type (I–VI), a scale of how skin reacts to sunlight.
Who can't join
- Have no disease that causes light sensitivity and take no medicines that cause light sensitivity.
- Have had keloids (thick, raised scars), which may form after a small skin sample is removed.
- Are allergic to local anesthetics (numbing medicines), antibiotics, or anticoagulants (blood thinners).
- Are pregnant.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Clinical diagnosis of psoriasis * Must be age 19 or older. * Must be Fitzpatrick skin type I, II, III, IV, V, VI. Exclusion Criteria: * Subjects who do not have photosensitive disease and are not on photosensitizing medications. * Subjects with a history of keloids (who are more likely to develop hypertrophic scars following skin biopsy). * Subjects who have an allergy to local anesthetics, antibiotics and/or anticoagulants. * Subjects who are pregnant.
Study sites (1)
AL
- The Kirklin Clinic · Birmingham, AL 35294Wendy Cantrell · Study contact · 205 502 9960 · wcantrell@uabmc.eduMore trials in Birmingham